Nevia Bio
Latest round
- Seed
Last raised
- Aug 2023
Total raised
- $3M
Investors
- 2
About Nevia Bio
, formerly known as Gina Life operates as a femtech company that develops a medical diagnostic platform for the early detection and prevention of ovarian cancer in women. The firm develops a medical platform that employs artificial intelligence and machine learning (AI/ML) algorithms to detect cancer in an early stage based on sample data collected from the vaginal discharge of a large dataset of women. The platform compares test samples from the patient with the database to detect cancer or other diseases in the early stage to help prevent diseases like ovarian cancer, endometriosis, etc.
Who invested in Nevia Bio
2 investors across 1 round
See all investors in Nevia Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 29, 2023
Amount
$3M
Investors
Questions about Nevia Bio
Who invested in Nevia Bio?
Nevia Bio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nevia Bio raised?
Nevia Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nevia Bio last raise money?
Nevia Bio's most recent round on record is a Seed, in Aug 2023.
What does Nevia Bio do?
, formerly known as Gina Life operates as a femtech company that develops a medical diagnostic platform for the early detection and prevention of ovarian cancer in women.
Where is Nevia Bio headquartered?
Nevia Bio is headquartered in Haifa, Israel.
Which VCs invest in companies like Nevia Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back healthcare it companies at Nevia Bio's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Nevia Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.